JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 114 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $509,699 | +66.7% | 275,513 | 0.0% | 0.33% | +222.3% |
| Q4 2022 | $305,819 | -52.6% | 275,513 | 0.0% | 0.10% | -56.4% |
| Q3 2022 | $645,000 | -22.8% | 275,513 | 0.0% | 0.24% | -11.6% |
| Q2 2022 | $835,000 | -55.4% | 275,513 | 0.0% | 0.27% | -30.3% |
| Q1 2022 | $1,871,000 | -18.7% | 275,513 | 0.0% | 0.38% | +17.8% |
| Q4 2021 | $2,301,000 | +12.4% | 275,513 | 0.0% | 0.32% | +41.3% |
| Q3 2021 | $2,047,000 | +9.3% | 275,513 | 0.0% | 0.23% | +8.5% |
| Q2 2021 | $1,873,000 | -33.8% | 275,513 | 0.0% | 0.21% | -20.9% |
| Q1 2021 | $2,830,000 | +20.7% | 275,513 | -17.7% | 0.27% | -23.9% |
| Q4 2020 | $2,345,000 | -14.2% | 334,965 | 0.0% | 0.35% | -52.4% |
| Q3 2020 | $2,733,000 | -25.3% | 334,965 | -36.8% | 0.74% | -26.1% |
| Q2 2020 | $3,657,000 | +45.3% | 529,965 | 0.0% | 1.00% | -4.0% |
| Q1 2020 | $2,517,000 | -45.6% | 529,965 | 0.0% | 1.04% | -29.3% |
| Q4 2019 | $4,627,000 | +162.2% | 529,965 | 0.0% | 1.47% | +170.3% |
| Q3 2019 | $1,765,000 | -32.7% | 529,965 | 0.0% | 0.54% | -18.5% |
| Q2 2019 | $2,623,000 | -60.1% | 529,965 | -50.0% | 0.67% | -51.8% |
| Q1 2019 | $6,572,000 | +268.0% | 1,059,930 | +100.0% | 1.39% | +4.9% |
| Q4 2018 | $1,786,000 | -48.2% | 529,965 | 0.0% | 1.32% | -18.8% |
| Q3 2018 | $3,445,000 | -15.1% | 529,965 | 0.0% | 1.63% | -45.6% |
| Q2 2018 | $4,060,000 | -65.7% | 529,965 | 0.0% | 3.00% | -74.3% |
| Q1 2018 | $11,845,000 | +60.3% | 529,965 | -8.6% | 11.64% | +117.8% |
| Q4 2017 | $7,391,000 | -18.2% | 579,650 | 0.0% | 5.34% | +4.6% |
| Q3 2017 | $9,031,000 | +11.1% | 579,650 | 0.0% | 5.11% | +0.7% |
| Q2 2017 | $8,132,000 | -36.2% | 579,650 | 0.0% | 5.08% | -38.8% |
| Q1 2017 | $12,747,000 | – | 579,650 | – | 8.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |